Haematological disorders disrupt the normal production, function, and lifecycle of blood cells and components. When bone marrow or circulating blood elements fail, the body's baseline physiology is compromised across multiple organ systems. Patients with conditions like sickle cell anemia, leukemia, or severe coagulopathies face chronic vulnerability because blood touches every living tissue.
Key underlying vulnerabilities include:
In sickle cell disease, abnormal hemoglobin polymerizes under low oxygen tension, causing red blood cells to stiffen into sickle shapes. These deformed cells obstruct microvascular blood flow, triggering localized tissue ischemia, severe pain crises, and eventual infarction.
Frequent sites of vaso-occlusion include:
Disorders involving platelets or clotting factors disrupt normal hemostasis, exposing patients to spontaneous or prolonged bleeding. Conditions such as hemophilia or severe thrombocytopenia prevent the formation of a stable fibrin plug.
Clinical manifestations of uncontrolled bleeding include:
Neutropenia and qualitative white blood cell defects strip the body of its primary cellular defense against invading microorganisms. Without adequate functional neutrophils, minor bacterial or fungal exposures rapidly escalate into systemic sepsis.
Patients with profound immunosuppression must be monitored for:
When hemoglobin levels plummet, the cardiovascular system attempts to compensate for reduced tissue oxygenation by increasing cardiac output. The heart pumps faster and harder, which over time leads to hyperdynamic circulation, cardiomegaly, and high-output heart failure.
| System | Compensatory Response | Long-term Consequence |
|---|---|---|
| Cardiovascular | Increased heart rate and stroke volume | Left ventricular hypertrophy and heart failure |
| Respiratory | Tachypnea to maximize alveolar oxygen uptake | Chronic pulmonary fatigue and dyspnea |
Failure to correct severe, chronic anemia inevitably exhausts myocardial reserve, precipitating fluid overload and pulmonary congestion.
Patients requiring chronic, repeated blood transfusions for conditions like thalassemia major inevitably accumulate excess iron. The human body lacks an active physiological mechanism to excrete excess iron, resulting in deposition within vital parenchymal organs.
Iron toxicity destroys tissue architecture in the:
Certain haematological states shift the hemostatic balance toward hypercoagulability, increasing the risk of abnormal clot formation within blood vessels. Conditions such as polycythemia vera, paroxysmal nocturnal hemoglobinuria, or severe thrombocytosis elevate blood viscosity or activate clotting cascades inappropriately.
Dangerous thromboembolic events include:
Managing patients with haematological disorders requires vigilant, continuous nursing assessment to detect subtle signs of impending crisis before catastrophic failure occurs. Nurses must monitor vital signs, laboratory trends, and perfusion status across every shift.
Essential nursing actions include: